For licensed healthcare professionals. The protocol figures below are drawn from published labeling and peer-reviewed literature for educational reference. They are not a prescription, not a recommendation, and not a substitute for the dispensing pharmacy's labeling or your own clinical judgment.
Longevity
NAD+
aka Nicotinamide Adenine Dinucleotide
Compounded Not WADA-listed
Coenzyme central to redox metabolism and sirtuin signaling. Compounded injectable form used off-label for energy/longevity.
At a glance
- Common vial size
- 500 mg
- Reference dose
- 100 mg
- Frequency
- 1–3× weekly
Reference titration protocol
50 → 75 → 100 mg, +25 mg per week, once daily.
| Step | Dose | Duration | Administrations / week |
|---|---|---|---|
| 1 | 50 mg | 1 weeks | 7× |
| 2 | 75 mg | 1 weeks | 7× |
| 3 | 100 mg | 1 weeks | 7× |
Reconstitution example
A 500 mg vial reconstituted with 3 mL of bacteriostatic water yields 166.667 mg/mL. Confirm the diluent and volume against the labeling that ships with the vial.
Open this configuration in the calculatorClinical notes
- Large vials — use 5 mL+ BAC water for workable concentration
Available formulations
Presentations carried across the VitaRelay pharmacy network, including 503A compounded, 503B outsourcing facility, and research & development sourcing. Pricing and state-level availability are shown to verified accounts only.
- Injectable503A
- Lyophilized PowderR&D
- Lyophilized Powder503B
- Nasal Spray503A
- Nasal StripsR&D
- Pen503B
References
Pricing and ordering are for verified accounts
VitaRelay serves licensed practices, prescribers, and pharmacies. Catalog pricing, availability by state, and ordering are available after your account is verified.
Also in Longevity
Epithalon
Tetrapeptide studied in Russian gerontology for telomerase activation and pineal regulation. Human data limited to small studies.
Rapamycin
mTOR inhibitor FDA-approved as an immunosuppressant; off-label longevity dosing typically intermittent low-dose oral.
Humanin
Mitochondrial-derived peptide implicated in cytoprotection, insulin sensitivity, and neuronal survival. Early-stage research.
DSIP
Nonapeptide studied for sleep architecture, stress modulation, and pain. Limited modern human trial data.
Glutathione
Major endogenous antioxidant tripeptide. Compounded injectable and IV forms often paired with NAD+ protocols.
